Variant report
Variant | nsv886463 |
---|---|
Chromosome Location | chr6:101922699-101951502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570947732 | chr6:101925214-101925215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538558395 | chr6:101925329-101925330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369325527 | chr6:101925339-101925340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144699343 | chr6:101925369-101925370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535454158 | chr6:101925406-101925407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs377285574 | chr6:101925446-101925447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553758361 | chr6:101925476-101925477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370817281 | chr6:101925483-101925484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545573684 | chr6:101925502-101925503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557964745 | chr6:101925566-101925567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374914343 | chr6:101925578-101925579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185187983 | chr6:101925587-101925588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543183273 | chr6:101925697-101925698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561661868 | chr6:101925707-101925708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529110464 | chr6:101925738-101925739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541822611 | chr6:101925845-101925846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189693971 | chr6:101925874-101925875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs74435623 | chr6:101925921-101925922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181330071 | chr6:101925964-101925965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148496519 | chr6:101925971-101925972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78012586 | chr6:101926015-101926016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570853727 | chr6:101926042-101926043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141905216 | chr6:101926074-101926075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185073740 | chr6:101926091-101926092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189834076 | chr6:101926095-101926096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150632654 | chr6:101926097-101926098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181835139 | chr6:101926170-101926171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140070395 | chr6:101926191-101926192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186134380 | chr6:101926193-101926194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143409357 | chr6:101926200-101926201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555095955 | chr6:101926280-101926281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573644762 | chr6:101926288-101926289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146725352 | chr6:101926330-101926331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191966820 | chr6:101926333-101926334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539702845 | chr6:101926338-101926339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572370797 | chr6:101926377-101926378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200846177 | chr6:101926382-101926383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566395026 | chr6:101926383-101926384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs5878666 | chr6:101926403-101926404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546144997 | chr6:101926425-101926426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369620977 | chr6:101926435-101926436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564433411 | chr6:101926440-101926441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2852533 | chr6:101926451-101926452 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs376406386 | chr6:101926489-101926490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542090277 | chr6:101926534-101926535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183489183 | chr6:101926535-101926536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541493553 | chr6:101926558-101926559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371276474 | chr6:101926559-101926560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550446361 | chr6:101926586-101926587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562260218 | chr6:101926603-101926604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21785460 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Obesity | 21045960 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Autism | 22543975 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:101925200-101926000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr6:101926000-101928600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr6:101928000-101928600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr6:101933000-101934600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr6:101933200-101934600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr6:101933400-101934600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr6:101933400-101934800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:101933800-101934200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr6:101933800-101934600 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr6:101933800-101934600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:101933800-101934600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr6:101934000-101934600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr6:101934000-101935000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr6:101950600-101951200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr6:101950600-101951200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr6:101950800-101951200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr6:101951200-101951600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |